Among middle-aged women, low creatinine-to-cystatin C ratio (CCR) at baseline is associated with lower fat-free muscl ...

COVID-19 was linked to a faster annual decline in kidney function than pneumonia, prompting study authors to call for closer ...

The FDA has granted accelerated approval to Vanrafia to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression.

The FDA has approved Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy (C3G), to reduce proteinuria.

Their findings showed that a low CCR at baseline was associated with lower fat-free muscle volumes and poorer gait speeds 6 years later. Survey results are published in the article “Low creatinine to ...

Because creatinine is made by your skeletal muscle cells, your baseline creatinine range is affected by your size and muscle mass. Bodybuilders might have higher creatinine levels, whereas women ...

GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.

Adults recently diagnosed with immunoglobulin A nephropathy who were assigned sparsentan as first-line therapy experienced rapid and sustained reductions in proteinuria, according to ...